Cargando…

A long way to the battlefront: CAR T cell therapy against solid cancers

Chimeric antigen receptors (CARs) are engineered synthetic receptors that redirect and reprogram T cells to tumor surface antigens for subsequent eradication. The unprecedented efficacy of CD19-CAR T cells against B-cell malignancies has inspired oncologists to extend these efforts for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhicai, Chen, Wei, Zhang, Xing, Cai, Zhiming, Huang, Weiren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603378/ https://www.ncbi.nlm.nih.gov/pubmed/31289581 http://dx.doi.org/10.7150/jca.30406

Ejemplares similares

PCCM at the Battlefront Against COVID-19 in Wuhan, China
por: Wu, Sinan, et al.
Publicado: (2020)

The emerging battlefront: Infectious diseases
por: Natarajan, Sundaram
Publicado: (2016)

Mitochondria and Viral Infection: Advances and Emerging Battlefronts
por: Sorouri, Mahsa, et al.
Publicado: (2022)

Battlefronts of evolutionary conflict between bacteria and animal hosts
por: Aleru, Omoshola, et al.
Publicado: (2020)

Food security and COVID-19 in Afghanistan: a two-sided battlefront
por: Ahmadi, Attaullah, et al.
Publicado: (2021)

First aid to the battlefront: life and letters of Sir Vincent Kennett-Barrington (1844–1903)
por: Summers, Anne
Publicado: (1993)

Evolutionary Profile for (Host and Viral) MLKL Indicates Its Activities as a Battlefront for Extensive Counteradaptation
por: Palmer, Suzette N, et al.
Publicado: (2021)

CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

Extracellular matrix protein 1 (ECM1) is associated with carcinogenesis potential of human bladder cancer
por: Wang, Zhicai, et al.
Publicado: (2019)

Enhancing CAR T-cell therapies against solid tumors: Mechanisms and reversion of resistance
por: Qin, Yue, et al.
Publicado: (2022)

CAR T-Cell Therapy in Children with Solid Tumors
por: Kulczycka, Marika, et al.
Publicado: (2023)

CAR-T cells: the long and winding road to solid tumors
por: D’Aloia, Maria Michela, et al.
Publicado: (2018)

Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR
por: Zhang, Angela Q., et al.
Publicado: (2023)

Clinical Investigations of CAR-T Cell Therapy for Solid Tumors
por: Chen, Kun, et al.
Publicado: (2022)

Bright future or blind alley? CAR-T cell therapy for solid tumors
por: Zhang, Kai, et al.
Publicado: (2023)

Gene modification strategies for next-generation CAR T cells against solid cancers
por: Tian, Yonggui, et al.
Publicado: (2020)

Engineering CAR-T Cells for Improved Function Against Solid Tumors
por: Morgan, Michael A., et al.
Publicado: (2018)

Current Progress in CAR-T Cell Therapy for Solid Tumors
por: Ma, Shuo, et al.
Publicado: (2019)

Hurdles to breakthrough in CAR T cell therapy of solid tumors
por: Marofi, Faroogh, et al.
Publicado: (2022)

CAR-T Therapies in Solid Tumors: Opportunities and Challenges
por: Guzman, Grace, et al.
Publicado: (2023)

Synthesizing AND gate minigene circuits based on CRISPReader for identification of bladder cancer cells
por: Liu, Yuchen, et al.
Publicado: (2020)

Lenalidomide Enhances CAR-T Cell Activity Against Solid Tumor Cells
por: Wang, Zhixiong, et al.
Publicado: (2020)

The interferon-γ receptor pathway: a new way to regulate CAR T cell-solid tumor cell adhesion
por: Hong, Lingjuan, et al.
Publicado: (2022)

Patient‐derived renal cell carcinoma organoids for personalized cancer therapy
por: Li, Zhichao, et al.
Publicado: (2022)

AB111. Synthesizing an AND gate genetic circuit for identification of bladder cancer cells based on CRISPR-Cas9
por: Liu, Yuchen, et al.
Publicado: (2014)

Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology
por: Watanabe, Keisuke, et al.
Publicado: (2018)

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
por: Knochelmann, Hannah M., et al.
Publicado: (2018)

CAR T cell therapy in solid tumors: a short review
por: Umut, Öykü, et al.
Publicado: (2021)

Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors
por: Boccalatte, Francesco, et al.
Publicado: (2022)

Combining chemotherapy with CAR-T cell therapy in treating solid tumors
por: Wang, Arthur Xuan, et al.
Publicado: (2023)

Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield
por: Jo, Yuna, et al.
Publicado: (2020)

Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
por: Valiullina, Aigul Kh., et al.
Publicado: (2023)

Combination therapy: A feasibility strategy for CAR-T cell therapy in the treatment of solid tumors
por: Xu, Jinjing, et al.
Publicado: (2018)

Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
por: Rossig, Claudia, et al.
Publicado: (2018)

Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
por: Kyte, Jon Amund
Publicado: (2022)

Mesothelin-targeted CAR-T cells for adoptive cell therapy of solid tumors
por: Zhang, Gui-Zhen, et al.
Publicado: (2019)

AB112. Constructing several amiRNAs with multiple targets to silence selectively cancer gene and to inhibit the growth of bladder cancer cells
por: Xin, Fu, et al.
Publicado: (2014)

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and tumor microenvironment, overcoming multiple obstacles of CAR T therapy for solid tumors
por: Wang, Yufeng, et al.
Publicado: (2023)

Binding and Efficacy of Anti-Robo4 CAR-T Cells against Solid Tumors
por: Hirobe, Sachiko, et al.
Publicado: (2022)

AB128. Inhibiting cell migration and cell invasion by silencing the transcription factor ETS-1 in human bladder cancer
por: Liu, Yuchen, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4cho2b13bugpkcekb9h7jkgia9